What question did this study set out to answer?

The aim is to enhance ferroptosis therapy for tumors using MoS2-doped iron oxide nanoparticles.

MoS 2 ‐Doped Iron Oxide Nanozyme with Co‐Catalytic Enhancement for Tumor Ferroptosis Guided by Magnetic Resonance Imaging

View Full Paper

Ask AI

Bookmark

Authors

Demonstrates improved tumor ferroptosis in a specific condition, suggesting a new therapeutic strategy.

The aim is to enhance ferroptosis therapy for tumors using MoS2-doped iron oxide nanoparticles.
Developed Fe3O4/MoS2@TAM/BSA nanoparticles.
Functionalized nanoparticles with tamoxifen and bovine serum albumin.
Assessed Fenton reaction efficiency and tumor growth inhibition.
Showed a 51.3% increase in Fenton activity and 4.3-fold increase in GSH consumption compared to Fe3O4 alone.
Achieved 70.6% tumor growth inhibition, significantly higher than Fe3O4's 20.8%.
Demonstrated a 17% reduction in MRI signal compared to Fe3O4.

Liu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark